Orasure Technologies (OSUR)
NASDAQ:OSUR
Want to see OSUR full AI Analyst Report?
Earnings Data
Report Date
Aug 11, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.27Last Year’s EPS
-0.26Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call presented a balanced picture: positive execution on cost and manufacturing initiatives led to gross margin expansion and sequential diagnostics growth, a strong cash position and ongoing buybacks support financial flexibility, and two FDA-submitted products plus near-shoring progress are meaningful near- to mid-term growth catalysts. Offsetting these positives are substantial operating losses, negative operating cash flow, elevated near-term operating expenses (including nonrecurring charges), muted demand in some Sample Management end markets due to slow NIH funding, and execution/timing risks associated with product ramps and near-shoring monetization. Given the mix of encouraging operational progress and clear near-term financial and execution risks, the overall tone is balanced.Company Guidance
Revenue Above Guidance and Sequential Growth
Q1 total revenue of $27.9 million, which came in above the midpoint of guidance and grew 4% sequentially.
Diagnostics Segment Strength
Diagnostics revenue of $16.9 million in Q1, with an approximately even split between U.S. and international sales and sequential growth of 12%.
Gross Margin Expansion
GAAP gross margin improved to 42.3% (from 41.1% in Q1 2025, +1.2 percentage points) and non-GAAP gross margin rose to 43.4% (from 41.7% in Q1 2025, +1.7 percentage points), driven by in-sourcing production and manufacturing efficiencies.
Strong Balance Sheet and Capital Returns
Ended the quarter with $177 million in cash and cash equivalents, zero debt, and continued share repurchases (deployed $5 million in Q1 for 1.8 million shares and $20 million repurchased over the last four quarters).
Near-Term Product Catalysts
Two FDA submissions in active review with anticipated midyear clearances: an OTC rapid molecular self-test for CT/NG on the Sherlock platform and the Colli-Pee at-home urine collection device. Management expects revenue from these launches to ramp in the second half of 2026.
International Near-Shoring and Market Expansion
Delivered initial orders to a near-shoring partner in Africa during Q1, expect additional initial orders from other partners in H2 2026, and are integrating BioMedomics and expanding SickleSCAN into new national health program markets—management referred to potential opportunity sizes in the 'millions.'
Focused R&D Investment with Planned Taper
R&D investment increased to $13.7 million in Q1 due to launch and production readiness activities for CT/NG and Colli-Pee, with management expecting R&D expense to taper in Q2 and Q3 as launch preparations conclude.
OSUR Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
OSUR Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 06, 2026 | $3.00 | $3.13 | +4.33% |
Feb 25, 2026 | $2.80 | $3.08 | +10.00% |
Nov 05, 2025 | $2.57 | $2.40 | -6.61% |
Aug 05, 2025 | $3.12 | $2.85 | -8.49% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Orasure Technologies (OSUR) report earnings?
Orasure Technologies (OSUR) is schdueled to report earning on Aug 11, 2026, After Close (Confirmed).
What is Orasure Technologies (OSUR) earnings time?
Orasure Technologies (OSUR) earnings time is at Aug 11, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is OSUR EPS forecast?
OSUR EPS forecast for the fiscal quarter 2026 (Q2) is -0.27.